Macrophage activation and antitumor activity of cyclohexyl-1,3-dioxepin and 4-methyl-2-pentonyl maleic anhydride copolymers.
D000818:Animals; D000970:Antineoplastic Agents; D001201:Ascites / Q000473:pathology; D001772:Blood Cell Count; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D005260:Female; D005663:Furans / Q000494:pharmacology*; D008262:Macrophage Activation / Q000187:drug effects*; D008264:Macrophages / Q000187:drug effects* / Q000201:enzymology; D008299:Maleic Anhydrides / Q000494:pharmacology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008970:Molecular Weight; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010544:Peroxidases / Q000378:metabolism; D000071228:Polyelectrolytes; D011108:Polymers / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D005663:Furans; D008299:Maleic Anhydrides; D010544:Peroxidases; D000071228:Polyelectrolytes; D011108:Polymers; C045871:4-methyl-2-pentonyl-maleic anhydride copolymer; C044929:2-cyclohexyl-1,3-dioxepin-maleic anhydride copolymer